Daniel Saltzman, PhD, MD
CHIEF OF PEDIATRIC SURGERY (U OF MN MED SCHOOL); CHIEF MEDICAL OFFICER (SALSPERA, LLC), UNIVERSITY OF MINNESOTA MEDICAL SCHOOL; SALSPERA, LLC
Oakdale, Minnesota, United States
Dr. Saltzman is the Chief of Pediatric Surgery at the University of Minnesota Medical School. He has authored over 130 articles (manuscripts and abstracts) published in the medical literature, has written 10 book chapters, and holds 5 patents. He has an active clinical practice where he has expertise in Pediatric Cancers, Gastrointestinal Disorders, and Chest Wall Deformities. Considered a renowned expert in the field of microbial immunotherapy, he has led an experimental therapeutic cancer immunotherapy laboratory for the last two decades The Saltzman Research Lab is considered a world leader in the use of bacteria to deliver immunomodulatory proteins directly to cancers. Dr. Saltzman is also the co-founder and CMO of Salspera. He has studied the use of attenuated Salmonella as a tumor-targeted vehicle to carry immune modulating proteins directly to the tumor microenvironment. He wrote the very first journal article ever published on the use of Salmonella for cancer therapy.